Profile
VU Venture Partners is a venture capital firm based in San Francisco, California, founded in 2018. The firm boasts a large investment team of over 70 professionals, significantly larger than the average VC fund. VU Venture Partners differentiates itself by its extensive deal flow and selective investment process, sourcing around 20,000 deals annually and investing in only about 0.1% of them.
The firm invests across multiple sectors including consumer, enterprise, fintech, healthcare, and proptech. They focus on early-stage investments, particularly pre-seed, seed, and Series A rounds, with typical check sizes ranging from $200K to $1M. VU Venture Partners operates globally, with a presence in North America, Asia-Pacific, and Europe, and manages a total AUM of over $100 million.
Notable investments by VU Venture Partners include HEARTio - diagnostic equipment, Natilus - aerospace and defense, Kangaroo Biomedical - biotechnology, Atomionics - electronic equipment and instruments, and Neuralink - therapeutic devices.
Industry
VU Venture Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
VU Venture Partners Fund II
|
Venture Capital (VC)
|
Consumer Products
Fintech
Healthcare Services
PropTech / ConTech
|
Pre-seed
Seed
Series A
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$0-1 m
|
$45 M
|
June 2018
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.